Research Daily Summary
Research Daily Summary: What Happened on November 13, 2026
Breast cancer atlas maps changes from in situ lesions to invasive disease
Other studies link microbiome profiles to hormone therapy response and examine heart scarring, drug-resistant bacteria and neural speech tracking.
Today in brief
An atlas spanning normal breast tissue, ductal carcinoma in situ and invasive cancer maps more than 850,000 cells and identifies features that may emerge before disease becomes invasive.1 In a six-month study, participants’ starting gut and vaginal microbiome profiles were linked to their response to menopausal hormone therapy.2
In mice, reducing the heart-scarring target AEBP1 improved function when done four weeks after a heart attack, but not after heart failure had advanced.3 A genetic analysis of vancomycin-resistant Enterococcus from nine Danish hospitals found that later samples appeared across all nine identified subclusters.4
A breast cancer cell atlas traces changes across disease stages
MD Anderson researchers used single-cell and spatial profiling to map normal breast tissue, ductal carcinoma in situ (DCIS) and invasive breast cancer, including changes in the tissue around tumors.1 The analysis covered 854,911 cells from 159 patients and spatial data from 39 samples, identifying nine cell types and 60 cell states.1
The research team said some features associated with invasive cancer may arise earlier than previously recognized.1 The team also found rings of supportive tissue and blood-vessel cells around DCIS lesions, which it said may create conditions favorable to tumor growth.1 Researchers plan to test whether features in the atlas can predict which lesions will become invasive.1
Microbiome profiles were linked to response to menopause hormone therapy
Over six months, menopausal hormone therapy was associated with changes across several microbiome sites, including a shift in vaginal microbes toward a pattern seen in reproductive-age women.2 Participants’ initial gut and vaginal microbiome profiles were linked to their clinical response. Combining gut microbiome features with clinical information predicted rapid symptom remission.2
Timing mattered when researchers reduced a heart-scarring target
In mice, reducing AEBP1 in heart fibroblasts improved heart function four weeks after a heart attack. Reducing it only after heart failure had advanced did not.3 Human heart samples showed higher AEBP1 expression in advanced heart failure, especially near injured areas. Lowering AEBP1 in diseased tissue reduced scarring and improved cell appearance.3
The researchers cautioned that eliminating scar formation could impair tissue repair.3 They said further work needs to establish when AEBP1 reduction might be appropriate, including after the initial healing phase.3
Danish hospital study traces diversification of vancomycin-resistant bacteria
Researchers analyzed 334 vancomycin-resistant Enterococcus faecium ST80 isolates collected at nine Danish hospitals from 2012 through 2020.4 They identified two main clusters and nine subclusters. The leading early subcluster accounted for 169 isolates and 72% of samples collected from 2012 to 2015.4 Samples collected from 2016 through 2020 appeared across all subclusters, which the authors interpreted as greater diversification.4
The study linked genetic variation to mutations, recombination and changes in accessory genes and plasmids, and identified eight recombination hotspots.4 The clone carried a phage-like plasmid element containing the vanA resistance operon and other antibiotic-resistance genes.4 Researcher Maria Miragaia said any of the linked antibiotics could select for bacteria carrying the full resistance package. She said reducing vancomycin use alone might not lower resistant bacteria if other linked drugs remain in use.4
Also worth knowing
-
Mount Sinai researchers mapped the AASS enzyme’s structure and found compounds that alter its activity, providing starting points for designing inhibitors for glutaric aciduria type 1.5
-
P
Children with developmental language disorder showed reduced tracking of slow speech patterns during story listening. Stronger low-frequency tracking was associated with better language performance.6
Also published
- Closing the global evidence gap in oncology, with Flatiron Health pharmaphorum
- Women feel the cold more keenly than men – and we may finally know why BioTechniques
- Correction: Ancient inversion polymorphisms associate with sexually selected traits across natural guppy populations PLOS Biology
- Not How Long. How Well. The Labs Report
- Inside Arbor’s CNS pipeline and next-generation gene editing Labiotech
- Vaccines could be a new frontier in KRAS targeting Nature Medicine
- Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer Cell Systems
- The patient in the conversation Nature Biomedical Engineering
- A unified and practical taxonomy for false discovery rate control in omics research Nature Biotechnology
- Immunogenicity risk assessment of novel modalities using new approach methodologies Nature Reviews Drug Discovery